Escitalopram oxalate for aphasia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Feb 2019: Trial registered, NCT03843463
  2. 18 Jul 2021: Trial started, NCT03843463

The trials

NCT03843463: Escitalopram and Language Intervention for Subacute Aphasia

State
Under way
Phase
Phase 2
People
88 planned
Started
18 Jul 2021
Primary completion
18 Feb 2027
Arms
Naming Treatment + Escitalopram
Results
None posted
  1. 18 Feb 2019: Trial registered
  2. 18 Jul 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Escitalopram 10mg, Lexapro.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.